Financials
| Audited Financial Statements Year Ended 2023 | May. 07, 2024 |
| Full Text of Accounts | May. 07, 2024 |
| Final Results | May. 07, 2024 |
| ANNUAL REPORT AND FINANCIAL STATEMENTS | Nov. 02, 2023 |
| Half-year Report | Sep. 28, 2023 |
| Annual Financial Report | Jul. 13, 2023 |
| Final Results | Apr. 24, 2023 |
Proxies
| Print of Ordinary and Special Resolutions | Jun. 28, 2024 |
| Result of AGM | Jun. 27, 2024 |
| Notice of AGM | Jun. 03, 2024 |
| Notice of Annual General Meeting | May. 16, 2023 |
| Results of AGM | Jun. 14, 2022 |
| Notice of Annual General Meeting | May. 20, 2022 |
Ownership Update
| Holding(s) in Company | May. 10, 2024 |
| NOTIFICATION OF MAJOR HOLDINGS | Apr. 10, 2024 |
| NOTIFICATION OF MAJOR HOLDINGS | Apr. 09, 2024 |
| NOTIFICATION OF MAJOR HOLDINGS | Apr. 09, 2024 |
| NOTIFICATION OF MAJOR HOLDINGS | Mar. 21, 2024 |
| Holding(s) in Company | Mar. 22, 2023 |
| Company Share Purchase by CEO | Aug. 15, 2022 |
Announcements
| Strengthening of Pre-Clinical Efforts | Jun. 27, 2024 |
| Receipt of Grant Funding | Jun. 12, 2024 |
| Receipt of Grant Funding | May. 30, 2024 |
| Restoration of Listing | May. 08, 2024 |
| Temporary Suspension | May. 01, 2024 |
| Total Voting Rights | Apr. 30, 2024 |
| Successful Placing and Subscription | Apr. 04, 2024 |
Prospectuses
| GENFLOW BIOSCIENCES PLC - Single prospectus | Jan. 07, 2022 |